QUOTE AND NEWS
FierceBiotech  Sep 29  Comment 
Novartis, Amgen chalk up PhIII migraine success to maintain lead over Lilly, Teva ntaylor Thu, 09/29/2016 - 03:37
newratings.com  Sep 28  Comment 
Novartis announces Phase III study shows AMG 334 significantly reduces monthly migraine days in people with episodic migraine Novartis International AG / Novartis announces Phase III study shows AMG 334 significantly reduces monthly migraine...
newratings.com  Sep 28  Comment 
Sandoz invites young entrepreneurs to enter Sandoz HACk, a global competition to help solve healthcare access challenges Novartis International AG / Sandoz invites young entrepreneurs to enter Sandoz HACk, a global competition to help solve...
FierceBiotech  Sep 27  Comment 
Novartis oncology vet to head up cancer I/O startup Neon slawrence Tue, 09/27/2016 - 09:38
The Economic Times  Sep 26  Comment 
Some of the searches in the past couple of months resulted in Devinder Ahuja joining Novelis as CFO from Novartis, DM Reddy moving to Hinduja and so on.
FiercePharma  Sep 26  Comment 
Novartis' Ilaris nets a trio of rare-disease nods in untapped markets chelfand Mon, 09/26/2016 - 15:33
FiercePharma  Sep 26  Comment 
Novartis hopes speedy new diagnostic gadget can help boost Xolair scripts chelfand Mon, 09/26/2016 - 07:37
Benzinga  Sep 26  Comment 
Think you know the markets? See if you can figure out what stock this is based on the clues and chart below.  One of this company's drugs achieved its Phase 3 primary endpoint Monday morning.  This stock hit an all-time high in June...
newratings.com  Sep 24  Comment 
BASEL (dpa-AFX) - Novartis (NVS) announced that the US Food and Drug Administration or FDA has granted three simultaneous approvals for the expanded use of Ilaris (canakinumab) to treat three rare and distinct types of Periodic Fever Syndromes: ...




 

Fuerralz? That's marvelously good to know.

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki